Welcome to the 12th Edition of International Conference on Endocrinology & Diabetology (Endocrinology 2020). It is a one-of-a-kind event showcasing the many facets and diversity of endocrinology and diabetes. All Over the world diabetes and endocrinology professionals, nurses and healthcare experts are expected to attend the two-day conference. The endocrine system is a network of glands that produce and release hormones that help control many important body functions, including the body's ability to change calories into energy that powers cells and organs. The endocrine system influences how your heart beats, how your bones and tissues grow, even your ability to make a baby. It plays a vital role in whether or not you develop diabetes, thyroid disease, growth disorders, sexual dysfunction, and a host of other hormone-related disorders. High blood glucose kills about 3.4 million people worldwide, annually. More than 80% of these deaths occur in low- and middle-income countries, and almost half are people aged less than 70 years. Diabetes deaths will be doubled between 2005 and 2030, as per WHO projections.
Prevalence of endocrine disorders is increasing among all ages in Europe, mostly due to increases in overweight and obesity, unhealthy diet and physical inactivity. There are approximately 60 million humans with diabetes in the European Region or approximately 10.3% of men and 9.6% of women, aged 25 years and over.
Medical doctors, patients, and health care providers consider the prevention of endocrine disorders as an essential tool to improve the general health status of the population. According to a recent statistical survey, the proportions of people suffering from the disease are expected to increase in the future. Realizing this imperative, EuroSciCon is set to organize 12th Edition of International Conference on Endocrinology & Diabetology to be held during July 20-21, 2020 at Barcelona, Spain with a view to promote awareness and enhance research aiming in developing solutions for the challenges encountered.
Organizing Committee invites the participants from all over the globe to take part in this annual flagship conference with the theme (write theme) Endocrinology 2020 will focus on the latest and exciting innovations in all areas of Diabetes and Endocrinology research and aims to proclaim knowledge and share new ideas amongst Endocrinologists, Diabetes expertise, Researchers, Professors, Scientific communities, Counselors, Delegates, Students, Business Professionals, and Executives. The Conference will have space for institutions and/or companies to present their services, products, innovations and research results.
SESSIONS & TRACKS
Track 1 : Biochemistry and Metabolism
Biochemical Metabolism is a pathway having arrangement of synthetic responses happening inside a cell. In a pathway, the underlying compound (metabolite) is adjusted by an arrangement of substance responses. These responses are catalyzed by catalysts, where the result of one chemical goes about as the substrate for the following. These chemicals regularly require dietary minerals, nutrients, and different cofactors to work.
- Physical and organic aspects of Biochemistry
- Intermediary metabolism, macro and micro-nutrients and inborn errors of metabolism
- Biochemical and molecular aspects of processes in the body
- Molecular interactions
Track 2 : Biology of Diabetes
Diabetes is a continual disease that occurs either whilst the pancreas does now not produce enough insulin or while the body can't effectively use the insulin it produces. The blood sugar level is controlled by a hormone called Insulin. Hyperglycemia, or raised blood sugar, is a commonplace impact of out of control diabetes and overtime end in serious harm to among the body's systems, particularly the nerves and blood vessels.
- Pathophysiology of the Metabolic Disorder
- Nutrition Therapy
- Pharmacotherapy for Glucose Management
- Pregnancy with Diabetes
- Complications of Diabetes
Track 3 : Child Nutrition
Nutrition is the observation of nutrients in food, how the body uses them, and the connection between diet, health, and disease. Proteins, carbohydrates, water, fat, vitamins, minerals and fiber are all nutrients. Nutritionists use ideas from molecular biology, biochemistry, and genetics to recognize how vitamins influence the human body. Nutrition also specializes in how human beings can use dietary choices to lessen the hazard of disease, what happens if someone has an excessive amount of or too little of. If people do not have the right stability of nutrients of their diet, their danger of growing positive health situations increases.
Diabetes mellitus is a meeting of metabolic ailments described by means of hyperglycemia coming about due to imperfections in insulin discharge, insulin activity, or each. The perpetual hyperglycemia of diabetes is associated with long haul harm, brokenness, and disappointment of different organs, mainly the eyes, kidneys, nerves, heart, and veins. Diabetic kidney sickness is perceived as the primary source of abundance mortality within the populace with type 1 diabetes. The main hypothesis is that overabundance calories are treated with the aid of the mitochondria bringing approximately amassing of superoxide radicals through the electron circulate chain. Novel Paradigms in Diabetic Complications, Diabetes, Pre-diabetes speaks to an upward push of plasma glucose over the ordinary range but beneath that of scientific diabetes. Prediabetes and Metabolic Syndrome, To extra, readily study both the pathogenesis and capacity restorative operators, proper creature models of kind 2 diabetes (T2D) Mellitus are required for Clinical preliminaries on creature fashions, sodium-glucose co-transport inhibitors go approximately as a singular process for the treatment of diabetes mellitus Type 2 diabetes is by using a wide margin the most well-known sort of diabetes in grown-ups (>ninety percent) and is described through hyperglycemia and variable ranges of insulin lack and competition in Clinical creation and analysis of diabetes mellitus in grown-ups.
- Microvascular and Macrovascular Complications of Diabetes
- Standards of Medical Care in Diabetes
- Diabetes and Your Joints
- Oral Manifestations of Diabetes
- Insulin Therapy
Track 5 : Diabetic encephalopathy
The affiliation of diabetes mellitus with gradually developing end-organ damage to the central nervous system (CNS). This hassle of both type 1 and type 2 diabetes may be noted as “diabetic encephalopathy”. Both microvascular and macrovascular cerebral diseases going on in diabetes and the direct neuronal damage caused by chronically multiplied intracellular glucose concentration are implicated in encephalopathy. However, it stays doubtful to what quantity the neuronal impairment is prompted directly with the aid of an expanded intracellular glucose level. Emerging evidence indicates that the modifications of C-peptide level, improved oxidative stress and consequent oxidative harm the located in hyperglycemic situations and diabetic encephalopathy begins in the mitochondria, that is the primary site of reactive oxygen species production. studies offer sparkling evidence supporting that aside from the vascular dependent mechanisms of brain dysfunction and oxidative and nitrative pressure, C-peptide also exerts a pivotal position in diabetic headaches consisting of encephalopathy.
- Clinical manifestations of diabetic encephalopathy
- Possible mechanisms of diabetic encephalopathy
- Risk factor control and therapies for diabetic encephalopathy
Track 6 : Diabetes- Types and its Complications
There are 3 main sorts of diabetes – type 1, type 2 and gestational.
• Type 1 diabetes can expand at any age but occurs most regularly in children and adolescents. When you have type 1 diabetes, your body produces very little or no insulin, because of this that you want daily insulin injections to hold blood glucose levels below control.
• Type 2 diabetes is more common in adults and bills for around 90% of all diabetes cases. When you have type 2 diabetes, your body does no longer makes correct use of the insulin that it produces. The cornerstone of type 2 diabetes treatment is a wholesome lifestyle, such as multiplied physical pastime and a healthy diet. However, over time most human beings with type 2 diabetes will require oral capsules and/or insulin to maintain their blood glucose levels below control.
• Gestational diabetes (GDM) is a sort of diabetes that is composed of excessive blood glucose during pregnancy and is associated with headaches to each mother and child. GDM typically disappears after being pregnant but women affected, and their youngsters are at extended danger of developing kind 2 diabetes later in life.
Acute complications consist of hypoglycemia, hyperglycemia, diabetic coma, and nonketotic hyperosmolar coma. Chronic headaches occur due to a mixture of microangiopathy, macrovascular disorder and immune dysfunction in the shape of an autoimmune disorder or bad immune response, maximum of which are difficult to manage. Microangiopathy can affect all critical organs, kidneys, coronary heart, and brain, as well as eyes, nerves, lungs and locally gums and feet. Macrovascular issues can lead to cardiovascular ailment which includes erectile disorder. Female infertility may also be due to endocrine dysfunction with impaired signaling on a molecular level. Complications of diabetes mellitus are acute and chronic. Risk factors for them may be modifiable or no longer modifiable. Overall, complications are far less common and much less excessive in people with well-controlled blood sugar levels. However, (non-modifiable) risk factors consisting of age at diabetes onset, kind of diabetes, gender and genetics play a role. Some genes appear to provide protection towards diabetic headaches, as visible in a subset of long-term diabetes kind 1 survivor without complications.
- Severe autoimmune diabetes (SAID)
- Severe insulin-deficient diabetes (SIDD)
- Severe insulin-resistant diabetes (SIRD)
- Mild obesity-related diabetes (MOD)
- Mild age-related diabetes (MARD)
Track 7 : Emerging Focus in Diabetes Research
Despite logical tendencies and higher human services conveniences, diabetes keeps on troubling modified sections, especially centers, and low-pay nations. The present styles assign the growth in untimely mortality, forcing a genuine danger to international improvement. The headway in science and innovation has found the extension of a more modern age of nanomedicine in tranquilize revelation. At that point, the documentation and clinical exam of bioactive fixings from flora have revised the examination of medicine disclosure and lead recognizable evidence for diabetes control.
Track 8 : Diabetic Nephropathy
Diabetic nephropathy (diabetic kidney sickness) is kidney harm that consequences from having diabetes. Having excessive blood glucose ranges due to diabetes can damage a part of the kidneys that filters your blood. The broken filter becomes ‘leaky’ and we could protein into your urine. For some human beings, diabetic nephropathy can development to continual kidney ailment and kidney failure. However, maximum people with diabetes do not broaden kidney disorder that progresses to kidney failure. The main function of kidneys is to filter waste products and extra water from the bloodstream so that they may be excreted within the shape of urine. This is achieved via a system of tubes and blood vessels known as nephrons. Inside the nephrons are tiny blood vessels referred to as capillaries and tiny urine-amassing tubes. One of the most important structures within the nephron is a collection of blood vessels known as the glomerulus, which acts as a filter. Having excessive blood glucose tiers can interfere with the function of the glomerulus. The filtering feature of the kidneys doesn’t work properly, and proteins start to leak from the blood into the urine. High blood glucose degrees can also purpose scarring of the glomerulus (referred to as glomerulosclerosis). As the scarring gets worse, the kidneys prevent being capable of clear out waste products from the blood. When enough glomeruli were broken, kidney failure outcomes. People who've diabetic nephropathy also often have excessive blood pressure. High blood pressure can similarly contribute to kidney damage.
Track 9: Diabetic Gastro Paresis
Diabetic gastroparesis refers to cases of the digestive circumstance gastroparesis that diabetes causes. During everyday digestion, the stomach contracts to assist down the meals and move it into the small intestine. Gastroparesis disrupts the belly's contraction, which may interrupt digestion. Diabetes can motive gastroparesis due to its outcomes on the anxious system. Both type 1 diabetes and type 2 diabetes can motive nerve damage. diabetes may cause damage to the vagus nerve. The vagus nerve controls the movement of meals through the belly. When the vagus nerve experiences damage, the muscles within the stomach and other parts of the digestive tract are not able to characteristic properly. When this happens, food can't move as quickly through the digestive system. Gastroparesis is also known as not on time gastric emptying.
Track 10 : Endocrine and Diabetes Biomarkers
A biomarker is defined as any substance, structure, or method that can be measured within the body or its products that impact or predict the incidence of outcome or disease. For the cause of predicting type 1 diabetes, a biomarker must be present in a subset of the population, and this subset ought to have a bias in the share of humans in whom type 1 diabetes develops. A biomarker must also be present a quantifiable danger for the improvement of type 1 diabetes within a defined period or diagnose a “stage” in the development of clinical r symptomatic type 1 diabetes. The maximum of the biomarkers used for the prediction of type 1 diabetes is islet-unique helping the idea that, before overt hyperglycemia, kind 1 diabetes is predominantly a focused disease instead of a systemic disease.
Atomic Biomarkers may be separated as "an indicator that is exactly measured and gaged as a pointer of typical natural methods, pathogenic methodology, or pharmacologic reactions to a pharmaceutical intercession.
Biomarkers have an essential influence on using medical trials and treating patients. Progress in sub-atomic diagnostics helps medicinal professionals make proficient, experimentally legitimate choices. The use of biomarkers in the improvement of anti-diabetes medicines will rely upon quickening our comprehension of the pathogenesis of diabetes and specifically its macrovascular entanglements. Procedural enhancements from distinctive fields, specifically tumors, are starting to exhibit the way towards better fashions of diabetes pathogenesis and atomic biomarker revelation.
- Prognostic marker
- Diabetic nephropathy marker
- Inflammatory markers: Type 2 diabetes
- Pharmacotherapy in treatment of diabetes
Track 11 : Endocrine Disorders
Diseases of the endocrine gadget are common conditions including diabetes mellitus, thyroid, and obesity. Endocrine sickness is characterized by way of mis regulated hormone release (a productive pituitary adenoma), irrelevant response to signaling (hypothyroidism), lack of a gland (diabetes mellitus type 1, dwindled erythropoiesis in continual kidney failure), or structural enlargement in an essential site inclusive of the thyroid (poisonous multinodular goiter). Hypofunction of endocrine glands can occur because of the loss of reserve, hyposecretion, agenesis, atrophy, or lively destruction. Hyperfunction occurs as a result of hypersecretion, hyperplastic, loss of suppression, or neoplastic change, or hyperstimulation. Endocrinopathies are labeled as primary, secondary, or tertiary. Primary endocrine disease inhibits the movement of downstream glands. The secondary endocrine ailment is indicative of trouble with the pituitary gland. Tertiary endocrine disease is associated with dysfunction of the hypothalamus and its freeing hormones.
Track 12 : Endocrine System and Diabetes
Diabetes affects how the body regulates blood glucose tiers. Insulin helps to reduce degrees of blood glucose while glucagon’s role is to grow blood glucose levels. In people without diabetes, insulin and glucagon work collectively to preserve blood glucose stages balanced.
In diabetes, the body either doesn’t produce enough insulin or doesn’t respond nicely to insulin causing an imbalance between the results of insulin and glucagon.
In type 1 diabetes, the human body isn’t capable of produce enough insulin and so blood glucose becomes too excessive except insulin is injected.
In type 2 diabetes, the body is unable to respond correctly to insulin, which could also result in higher blood glucose tiers. Medications for kind 2 diabetes include the ones which help to growth insulin sensitivity, those which stimulate the pancreas to release extra insulin and other medications which inhibit the release of glucagon.
- The role of the endocrine system
- The endocrine system and energy metabolism
- Effects of diabetes on endocrine systems
Track 13 : Genetics of diabetes
Diabetes mellitus is a heterogeneous organization of disorders characterized by persistent hyperglycemia. The two maximum common forms of diabetes are type 1 diabetes (T1D, previously referred to as insulin-dependent diabetes or IDDM) and type 2 diabetes (T2D, previously known as non-insulin-dependent diabetes or NIDDM). Both are due to a mixture of genetic and environmental risk factors. However, there are different rare styles of diabetes that might be without delay inherited. These encompass maturity onset diabetes inside the young (MODY), and diabetes due to mutations in mitochondrial DNA.
Track 14 : Genetics of Obesity
Obesity is a condition that occurs when a person’s body accumulates and stores excessive quantities of body fat. The modernization of our society has contributed to higher quotes of weight problems via an environment that promotes extended calorie intake and decreased bodily activity. However, recent studies endorse those genetics contribute to 40-70% of obesity with the invention of greater than 50 genes that are strongly related to obesity. While changes in the environment have drastically extended obesity costs during the last 20 years, the presence or absence of genetic factors guard us against or predispose us to obesity. Rare single-gene defects reason intense obesity beginning in early formative years and are related to extremely excessive tiers of hunger. Individuals who developed intense obesity earlier than the age of 2 should keep in mind speak to a weight problems medicine specialist approximately being screened. More commonly, people who've obesity have more than one gene that predisposes them to benefit extra weight. One such gene is the fat mass and weight problems-associated gene (FTO), which is found in as much as 43% of the population. In the presence of comfortably on hand food, people with the fats mass and obesity-related gene may additionally have demanding situations limiting their caloric consumption.
Track 15 : Insulin Analogues and Glucose Sensors
An analog refers to something that is similar or “analogous” to something else. Therefore, “insulin” analogs are analogs that have been designed to mimic the body’s natural sample of insulin release. These synthetic-made insulins are the analogs of human insulin. However, they have minor structural or amino acid modifications that supply them special applicable characteristics when injected beneath the skin. Once absorbed, they act on cells like human insulin, however, are absorbed from fat tissue more predictably. They are of two types namely:
A tiny glucose-sensing device known as a "sensor" is inserted just underneath the skin (subcutaneous tissue). It's very much like the insertion of an insulin pump catheter. Sensors are typically inserted inside the stomach or higher buttock area, and tape is used to maintain them in place. The sensor measures the extent of glucose in the interstitial fluid (fluid surrounding the cell) every 10 seconds and changes it into an electrical signal. The signal represents the quantity of sugar inside the blood.
- Rapid Acting Insulin Analogs
- Long Acting Insulin Analogs
- Glucose Monitoring Methods
- Electrical transducers: Electrochemical sensors and semiconductor molecular sensors
- Glucose Biosensors
- Sensor Materials, Technologies and Applications
Track 16 : Lipid Metabolism and Diabetes
Diabetes mellitus is the most frequent endogenous motive of fats metabolism-disorder. In diabetics, the threat for arteriosclerosis is significantly high and the clinical significance of hyperlipidemia should be expected extra serious as in non-diabetics. The principal abnormality of fat metabolism in diabetes is hypertriglyceridemia due to a boom of triglyceride-carrying lipoproteins, the chylomicrons and the very-low-density lipoproteins. In type I-diabetics the decisive pathogenetic factor for hypertriglyceridemia is the impaired degradation of VLDL and the reduced chylomicron-clearance, because of decreased interest of the lipoprotein lipase. In ketoacidosis, there may be additional growth in hepatic VLDL-triglyceride-production because of extended lipolysis with increased free-fatty-acid flux. Total LDL cholesterol in-kind I-diabetics is handiest drastically expanded whilst metabolic control is poor, low-density lipoprotein (LDL-)-cholesterol-levels can be extended and high-density lipoprotein (HDL-)cholesterol reduced independence on the metabolic manipulate. In type II-diabetics the decisive pathogenetic factor for hypertriglyceridemia is improved VLDL-triglyceride-synthesis in the liver especially because of augmented free-fatty-acid flux. Additionally, the hobby of the lipoprotein lipase may be reduced. Usually, in non-insulin-established diabetics, LDL- cholesterol-levels may be seen expanded and HDL-cholesterol-concentration reduced in correlation with the metabolic manage. Primary hyperlipoproteinemia appears regularly in diabetics, but this may be explained by using the association with weight problems in type II-diabetics.
Track 17 : Molecular & Cellular Endocrinology
Endocrinology is a branch of biology and remedy managing the endocrine device, its diseases, and its secretions referred to as hormones. It is also concerned with the integration of developmental activities proliferation, growth, and differentiation, and the psychological or behavioral aspects of metabolism, growth, and development, tissue function, sleep, digestion, respiration, excretion, mood, stress, lactation, movement, reproduction, and sensory perception because of hormones. Specializations encompass molecular and mobile endocrinology.
The endocrine system consists of several glands, all in special components of the body, that secrete hormones without delay into the blood rather than into a duct machine. Therefore, endocrine glands are referred to as ductless glands. Hormones have many specific capabilities and modes of action; one hormone can also have several consequences on exceptional target organs, and, conversely, one target organ may be affected by a couple of hormones.
- Endocrine Genetics
- Advances in endocrine diagnosis
- Pediatric Endocrinology
- Endocrinology and Metabolism
Track 18 : Obesity
Obesity is a medical situation in which excess body fats have accrued to the extent that it could have a negative effect on health. People are normally considered obese whilst their body mass index (BMI), a measurement obtained by way of dividing a person's weight by way of the rectangular of the person's height, is over 30 kg/m2; the range 25–30 kg/m2 is described as overweight. Some East Asian countries use decrease values. Obesity will increase the probability of various illnesses and conditions like cardiovascular sicknesses, type 2 diabetes, obstructive sleep apnea, certain types of cancer, osteoarthritis, and depression.
Obesity is most generally as a result of an aggregate of immoderate food consumption, lack of physical activity, and genetic susceptibility. A few instances are caused overall by means of genes, endocrine disorders, medications, or mental disorder. The view that overweight humans devour little yet gain weight because of a sluggish metabolism isn't always medically supported. On average, obese humans have a greater electricity expenditure than their normal counterparts because of the energy required to maintain an increased body mass.
Obesity is commonly preventable through an aggregate of social adjustments and personal choices. Changes to weight loss program and workout are the main treatments. Diet excellent can be stepped forward by way of lowering the consumption of electricity-dense foods, including those high in fats or sugars, and by using increasing the intake of dietary fiber. Medications may be used, in conjunction with an appropriate food regimen, to reduce appetite or decrease fats absorption. If diet, exercise, and medication aren't effective, a gastric balloon or surgical operation can be achieved to reduce stomach quantity or length of the intestines, main to feeling full earlier or a reduced potential to soak up nutrients from food. Obesity is a main preventable purpose of death worldwide, with growing prices in adults and children.
Track 19 : Stem Cell Treatment in Diabetes
Stem cells are a form of cell that is but to broaden a specific set of traits. However, what stem cells have in abundance is the capacity to broaden into several forms. To cure kind 1 diabetes, stem cellular replacement desires to be more than virtually a case of swapping insulin-generating cells from a healthful pancreas with those destroyed by diabetes in a diabetic affected person. Numerous complications preclude in this treatment. Islet cellular transplants are one form of manner that has been demonstrated effectively. In type 1 diabetes, the body’s immune system turns into programmed to attack the beta cells, so the affected person must take immunosuppressant tablets to prevent this from happening. In the future, it may be viable to grow islet cells from affected person’s present islet cells, however, an affected person with type 1 diabetes could still need immune suppressants to prevent the cells being destroyed.
Track 20 : Psychoneuroendocrinology
Psychoneuroendocrinology is the clinical approach of hormone fluctuations and their courting to human behavior. It can be regarded from the perspective of psychiatry, wherein certain mood disorders, that are related to neuroendocrine or hormonal adjustments affecting the brain. It may additionally be regarded from the angle of endocrinology, where certain endocrine disorders may be related to poor health consequences and psychiatric illness. Brain dysfunctions associated with the hypothalamus-pituitary-adrenal axis HPA axis can affect the endocrine system, which in flip can bring about physiological and psychological symptoms. This complex combo of psychiatry, psychology, neurology, biochemistry, and endocrinology is needed to comprehensively recognize and treat signs and symptoms related to the brain, endocrine system (hormones), and mental health.
- Premenstrual Syndrome (PMS) and Premenstrual Dysphoric Disorder
- Postpartum Depression (PPD)
- Postpartum Psychosis
Track 21 : Pathophysiology of Diabetes
Genetic and environmental risk elements impact inflammation, autoimmunity, and metabolic stress. These states affect β-cell mass and/or characteristic such that insulin degrees are ultimately not able to respond sufficiently to insulin demands, leading to hyperglycemia ranges enough to diagnose diabetes. In some cases, genetic and environmental risk factors and gene-environment interactions can directly affect β-cell mass and/or function. Regardless of the pathophysiology of diabetes, chronic excessive blood glucose stages are related to microvascular and macrovascular complications that increase morbidity and mortality for people with diabetes. This model positions β-mobile destruction and/or dysfunction as the necessary not unusual element to all types of diabetes.
Track 22 : Reproductive Endocrinology and Infertility
Reproductive endocrinology and infertility (REI) is a surgical subspecialty of obstetrics and gynecology that trains physicians in reproductive medicine addressing hormonal functioning as it pertains to a replica as properly as the issue of infertility. While maximum REI professionals primarily focus on the remedy of infertility, reproductive endocrinologists are skilled to also examine and treat hormonal dysfunctions in women and males out of doors infertility. Reproductive endocrinologists have specialty schooling in obstetrics and gynecology (ob-gyn) before they undergo sub-specialty schooling (fellowship) in REI.
- Polycystic ovarian syndrome (PCOS)
- Hypothalamic pituitary dysfunction
- A congenital adrenal hyperplasia
- Tubal factor infertility
- Male factor infertility
- In vitro fertilization (IVF)
- Fertility preservation
- Congenital uterine anomalies
- Other disorders of the female reproductive tract
Track 23 : Adrenal disorders
The adrenal glands are small glands positioned on top of each kidney. They produce very critical hormonelike cortisols and sex hormone. Cortisol allows you to respond to pressure and has many other essential functions. With adrenal gland problems, your glands make too much or not enough hormones. In Cushing's syndrome, there's an excessive amount of cortisol, while with Addison's disease, there is too little. Some people not able to make enough cortisol from their birth.
Causes of adrenal gland disorders include:
- Genetic mutations
- Tumors such as pheochromocytomas
- A hassle in another gland, such as the pituitary, which enables to regulate the adrenal gland
- Certain medicines
- Adrenal gland tumors
- Addison’s disease
- Adrenal gland suppression
- Congenital Adrenal Hyperplasia
- Cushing syndrome
- Adrenocortical Carcinoma
Track 24 : Thyroid Disorders
Through the hormones, it produces, the thyroid gland affects almost all the metabolic procedures on your body. Thyroid disorders can range from a small, harmless goitre (enlarged gland) that wishes no treatment to life-threatening cancer. The maximum commonplace thyroid issues involve bizarre manufacturing of thyroid hormones. Too plenty of thyroid hormone results in a condition referred to as hyperthyroidism. Insufficient hormone manufacturing leads to hypothyroidism. Although the effects can be unpleasant or uncomfortable, maximum thyroid problems may be managed well if properly recognized and treated.
- Hashimoto’s disease
- Graves’ disease
- Thyroid nodules
- Preventing thyroid dysfunction
Track 25 : Pituitary Disorders
A pituitary disorder is a disorder frequently affecting the pituitary gland. Excess production or underproduction of a pituitary hormone will affect the respective end-organ. For example, inadequate production (hyposecretion) of thyroid-stimulating hormone (TSH) in the pituitary gland will motive hypothyroidism, even as overproduction (hypersecretion) of TSH will motive hyperthyroidism. Thyroids caused by the pituitary gland is much less not unusual though, accounting for much less than 10% of all hypothyroidism instances and much less than 1% of hyperthyroidism instances.
- Cushing’s Syndrome
- Growth Hormone deficiency
- Syndrome of inappropriate antidiuretic hormone
- Diabetes insipidus
- Pickardt-Fahlbusch Syndrome
- Sheehan Syndrome
Track 26 : Insulin producing implants
About 10 per cent of the 422 million people who've diabetes worldwide has type 1 diabetes, which is because the body's immune system mistakenly attacks cells inside the pancreas that make insulin. A credit-card-sized implant, referred to as “PEC-Direct”, contain cells derived from stem cells that can mature in the frame into the specialized islet cells that get destroyed in kind 1 diabetes. The implant sits just beneath the skin, inside the forearm, for example, and is supposed to routinely compensate for the lacking islet cells, releasing insulin while blood sugar tiers get too high.
Track 27 : Hypophysitis
Hypophysitis is a rare condition which involves the extreme or chronic inflammation of the pituitary gland or pituitary stalk. The most common form is lymphocytic Hypophysitis which is assumed to be an autoimmune disorder. It was believed to affect women during or after pregnancy, it is now acknowledged as a disease affecting both males and females and over a large age range. In addition, a new form has currently been defined in patients receiving immunotherapy remedy for cancer – basically those with metastatic cancer being dealt with anti-CTLA4 and anti-PDi treatment.
Track 28 : Hereditary paragangliomas
Hereditary paraganglioma-pheochromocytoma is an inherited situation characterized by the growth of noncancerous (benign) tumors in structures referred to as paraganglia. Paraganglia are groups of cells which can be found close to nerve mobile bunches known as ganglia. A tumor concerning the paraganglia is referred to as a paraganglioma. A type of paraganglioma called a pheochromocytoma develops inside the adrenal glands, which are placed on top of every kidney and produce hormones in response to stress. Other styles of paraganglioma are typically discovered in the head, neck, or trunk. People with hereditary paraganglioma-pheochromocytoma broaden one or more paragangliomas, which may encompass pheochromocytomas.
Pheochromocytomas and some different paragangliomas are associated with ganglia of the sympathetic nervous machine. The sympathetic nervous device controls the "fight-or-flight" reaction, a chain of changes inside the body due to hormones released in response to stress. Sympathetic paragangliomas located out of doors the adrenal glands, normally inside the abdomen, are referred to as extra-adrenal paragangliomas. Most sympathetic paragangliomas, which includes pheochromocytomas, produce hormones called catecholamines, together with epinephrine (adrenaline) or norepinephrine. These extra catecholamines can cause symptoms and symptoms consisting of excessive blood pressure (hypertension), episodes of rapid heartbeat (palpitations), headaches, or sweating.
Track 29 : Diabetic Retinopathy
Diabetic retinopathy (DR), the most usual trouble of diabetes, is the leading purpose of preventable visible impairment. In general, DR is clinically defined based on the observation of strange fundus vascular lesions, inclusive of microaneurysms, hemorrhages, tough exudates, and cotton wool spots. However, experimental and clinical research have shown that neurodegenerative changes, including lack of ganglion cells and glial reactivity, also are early events in the pathogenesis of DR. The lack of ganglion cells impacts retinal ganglion cell layer and retinal nerve fiber layer (RNFL) thickness and decreased thickness of these layers has been detected in medical and animal research.
Track 30 : Primary Aldosteronism
Primary aldosteronism, also known as number one hyperaldosteronism or Conn's syndrome, refers to the excess production of the hormone aldosterone from the adrenal glands, ensuing in low renin levels. This abnormality is caused by hyperplasia or tumors. Many be afflicted by fatigue, potassium deficiency and excessive blood stress which may purpose negative vision, confusion or headaches. Symptoms might also consist of: muscular aches and weakness, muscle spasms, low back and flank pain from the kidneys, trembling, tingling sensations, numbness and immoderate urination. Complications include cardiovascular disease which includes stroke, myocardial infarction, kidney failure and atypical heart rhythms.
Primary hyperaldosteronism has some of causes. About 33% of cases are due to an adrenal adenoma that produces aldosterone, and 66% of instances are due to an enlargement of both adrenal glands. Other unusual causes include adrenal cancers and an inherited disorder called familial hyperaldosteronism. Some advocate screening people with high blood strain who are at improved risk, even as others recommend screening each person with high blood strain for the disease. Screening is generally carried out by means of measuring the aldosterone-to-renin ratio within the blood, with similarly trying out used to verify positive results. While low blood potassium is classically defined in number one hyperaldosteronism, this is only found in about a quarter of human beings. To decide the underlying purpose, clinical imaging is carried out.
Some cases can be cured via disposing of the adenoma by using surgery. A single adrenal gland will also be removed in cases where simplest one is enlarged. In cases because of enlargement of each gland, treatment is common with medications called aldosterone antagonists along with spironolactone or eplerenone. Other medicines for excessive blood pressure and a low salt diet may also be needed. Some people with familial hyperaldosteronism can be dealt with with the steroid dexamethasone.Primary aldosteronism is found in about 10% of people with excessive blood stress. It occurs more regularly in ladies than men. Often, it starts in those between 30 and 50 years of age.
Global diabetes mind gadgets and medications advertise is relied upon to achieve USD 85,591.2 million by 2022, upheld by a CAGR of 5.2% amid the conjecture time of 2017 to 2022. The global diabetes mind gadgets and medications showcase is predominantly determined by the expanding frequency and pervasiveness of diabetes, innovative progressions, rising stoutness rate, and expanding stationary way of life and uncalled for slim down. Be that as it may, surprising expense related with conclusion and treatment, repayment issues, and absence of mindfulness is required to block the development of diabetes mind gadgets and medications market to some degree. Improvements of new details and insulin conveyance advances fill in as an open door for this market, while stringent controls and enrollment process for the diabetes mind gadgets and medications postures huge test for the development of diabetes mind gadgets and medications showcase. Market Segmentation The worldwide diabetes mind gadgets and medications showcase is for the most part portioned by kind of gadgets and medications. The diabetes mind gadgets showcase by type is additionally fragmented into diabetes checking gadgets and insulin conveyance gadgets. The medications showcase by type is additionally sectioned into insulin, oral-hypoglycemic specialists, and non-insulin injectable. Diabetes mind drugs showcase commanded the general market in 2016, and is relied upon to develop fundamentally in the following 5-10 years. The extensive offer of this market is essentially credited to the tremendous interest for insulin and oral hypoglycemic medications for the treatment of sort I and II diabetes. Conference Image Geographic Overview Geologically, the worldwide diabetes mind gadgets and medications advertise is divided into five noteworthy areas, to be specific North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. These districts are additionally dissected at a nation level with the point by point subjective and quantitative examination. North America represented the real offer in the worldwide diabetes mind gadgets and medications showcase in 2016, trailed by Europe, and Asia-Pacific. The significant offer of the North America is mostly credited to the huge and developing base of diabetic patients, entrenched social insurance framework, higher appropriation of mechanically inventive diabetic care items, expanding research on diabetes, and nearness of huge number of driving players in the market. In any case, Asia-Pacific area is anticipated to develop at a speediest CAGR amid the figure time frame, because of expanding turning gray populace, rising weight of diabetic populace, different government activities to build the mindfulness and counteractive action of sicknesses, and expanding stationary ways of life in creating nations, for example, India, and China.
Top Diabetes and Endocrinology Universities Worldwide:
University of California | Diabetes conferences | University in Chicago | Health Sciences University | Type 1 diabetes conferences | Columbia University | University in Los Angeles | Diabetes congress | Cornell University | Stanford University | University of the Pacific | Diabetes treatment conferences | The University of Washington | Emory University | The University of Pittsburgh | Vanderbilt University | Obesity conferences | University in New York City | The University of Texas | The University of Southern California | The Boston University | Nutrition conferences | Case Western Reserve University | University of Iowa | Texas Tech University System | University in Sacramento | Endocrinology conferences | The University of Nebraska | The University of Florida University of Minnesota | Diabetes conferences 2019 USA | Georgetown University | Brown University | The Rowan University | Diabetes mellitus conferences | East Carolina University | Pennsylvania University | The University of Alabama | Diabetes conferences Europe | Saint Louis University | The University of Colorado | The Ohio State University | Diabetes meeting 2019 | Nova Southeastern University | The University of Southern California | Metabolic syndrome conferences | Case Western Reserve University | The University of Alabama | The University of Colorado | Nova South-eastern University | Pediatric diabetes Columbia University | The University of North Carolina | Cornell University Stanford University | University in Sacramento | Diabetes congress | The University of Nebraska | The University of Florida | University of Minnesota | Brown University | Diabetes conferences | The Rowan University | The University of Nebraska | Georgetown University | Pennsylvania University | University of South Alabama | Type 1 diabetes conferences | University of Colorado | George Washington University | Florida International University | University of Miami Leonard | Type 2 diabetes conferences | Florida Atlantic University | University of Illinois | Loyola University Chicago | Northwestern University | Indiana University | Diabetes congress | University of Kansas | Johns Hopkins University | Louisiana State University | Harvard Medical School | Obesity conferences | University of Massachusett | Michigan State University | Wayne State University | Western Michigan University | Washington University | Endocrinology conferences | Saint Louis University | University of Nevada | Albany Medical College | Diabetes conferences 2019 USA | Columbia University New York Medical College | State University of New York | Diabetes mellitus conferences | University of Rochester | Weill Cornell Medical College
Asia Pacific and Middle East Universities:
National University of Singapore | Peking University | Tsinghua University | Diabetes conferences | Nanyang Technological University | University of Hong Kong | Pohang University of Science and Technology | Seoul National University | Type 1 diabetes conferences | Chinese University of Hong Kong | University of Science and Technology of China | Fudan University | Hong Kong Polytechnic University | Zhejiang University, Korea University | University of Otago | Type 2 diabetes conferences | National Taiwan University | Nanjing University | University of Newcastle | Tohoku University | Charles Darwin University | Diabetes treatment conferences | University of Wollongong | Osaka University | National Tsing Hua University | University of Tasmania | Deakin University | Obesity conferences | National Chiao Tung University | Toyota Technological Institute | Al-Beroni University | Ghalib University | Diabetes congress | Herat University | Ibne-sina Balkh Medical School | Kabul Medical University | Kandahar University | Endocrinology conferences | Nangarhar University | Spinghar Higher Education Centre | Armenian Medical Institute | Yerevan Haybusak University | Yerevan State Medical University | Diabetes conferences 2019 USA | Akaki Tsereteli State University | David Agmashenebeli University of Georgia | Tbilisi State Medical University | Tbilisi State University | Hashemite University | Diabetes mellitus conferences | Jordan University of Science and Technology | Mutah University | University of Jordan | Defense Services Medical Academy (DSMA) | Diabetes conferences Europe | University of Dental Medicine | University of Medicine 2 | University of Nursing | Chinese University of Hong Kong | Diabetes meeting 2019 | National University of Singapore | Peking University | Tsinghua University | Metabolic syndrome conferences | Fudan University | Nanyang Technological University | University of Hong Kong | Tohoku University | Pediatric diabetes | Charles Darwin University | Pohang University of Science and Technology | Seoul National University | National Chiao Tung University | Diabetes conferences | Hong Kong Polytechnic University | Zhejiang University Korea University | National Taiwan University | Nagoya University | Diabetes congress | Toyota Technological Institute | International University, Cambodia (IU) | University of Health Sciences – Cambodia (UHS-C) | Endocrinology conferences | University of Puthisastra | Osh State University | Asian Medical Institute | International School of Medicine Kyrgyzstan | Diabetes conferences Europe | Jalalabad State University | Kyrgyz-Russian Slavic University | Kyrgyz State Medical Academy | Medical Institute, Osh State University | Endocrinology conferences | International Medical Institute, Bishkek | American University of Beirut | Lebanese American University
University of Silesia | Wroclaw Medical University | Diabetes conferences | Bogomolets National Medical University | University of Zagreb | University of Cambridge | Type 1 diabetes conferences | University of Brighton | Plymouth University | University of Exeter | Type 2 diabetes conferences | Swansea University | University College London | University of Bristol | Diabetes treatment conferences | Ecole Polytechnique Federale de Lausanne | University of Edinburgh | Kings College London | Obesity conferences | University of Oxford | Swiss Federal Institute of Technology | University of Bristol | Nutrition conferences | Wroclaw Medical University | University of Zagreb | University of Sussex | Endocrinology conferences | Kings College London | University of Brighton | Plymouth University | Diabetes conferences 2019 USA | Swansea University | Federal de Lausanne | University of Athens | University of Crete | University of Ioannina | Diabetes mellitus conferences | University of Patras | University of Thessaloniki | University of Thessaly | University of Thrace | Diabetes meeting 2019 | Trinity College Dublin | University College Cork | University College Dublin | University of Limerick | Pediatric diabetes | University of Bologna | University of Catania | National University of Ireland, Galway | Royal College of Surgeons in Ireland | Diabetes conferences Europe | University of Ferrara | University of Modena and Reggio Emilia, Modena | University of Parma | University of Messina | University of Palermo | Diabetes congress | Albert Ludwig University of Freiburg | Ruprecht Karl University of Heidelberg | Heidelberg-Mannheim Eberhard Karl | University of Tübingen | Diabetes conferences | University of Ulm | University of Eastern Finland | University of Helsinki | University of Oulu | University of Tampere | University of Turku | Endocrinology conferences | Medical University Pleven | Medical University of Plovdiv | Medical University of Sofia | Medical University of Varna | Sofia University | Obesity conferences | Trakia University of Stara Zagora | Medical University of Innsbruck | Karl Landsteiner University of Health Sciences | Johannes Kepler University Linz | Medical University of Graz | Medical University of Vienna | Paracelsus Medical University
Diabetes and Endocrinology Societies Worldwide : -
American Societies -
Diabetes Technology Society | Pediatric Endocrinology Nursing Society | American Diabetes Association | Diabetes conferences | American Association of Diabetes Educators | Canadian Diabetes Association | American Association for Clinical Endocrinology Diabetes Canada | Type 1 diabetes conferences | Swiss Diabetes Society | American Association of Clinical Endocrinologists | American Association of Clinical Endocrinologists | Type 2 diabetes conferences | Society for Endocrinology | Endocrine Society | The American Association of Endocrine Surgeons, USA | Diabetes congress | Society for Reproductive Endocrinology and Infertility, USA | American Pediatric Society, USA | American Society for Parenteral and Enteral Nutrition, USA | Obesity conferences | Society for Nutrition Education and Behavior, USA | Pediatric Endocrinology Nursing Society, USA | EuropeanSociety for Pediatric Endocrinology | Nutrition conferences | Pediatric Endocrinology and Diabetes Associates, USA | Society for the Study of Inborn Errors of Metabolism (SSIEM) | Endocrinology conferences | Society for Inherited Metabolic Disorders (SIMD), USA | American Diabetes Association, USA | American Society of Hypertension, USA | Diabetes conferences 2019 USA | Brazilian Society of Cardiology, Brazil | American Association of Clinical Endocrinologists, USA | Canadian Diabetes Association (Canada) | Diabetes mellitus conferences | The Endocrine Society of Australia, Australia | The American Association of Clinical Endocrinologists | Diabetes conferences Europe | American Association of Diabetes Educators | American Medical Association | Association of Juvenile Diabetes | Diabetes meeting 2019 | Canadian Diabetes Association | Mexican Diabetes Federation | Juvenile Diabetes Cure Alliance (JDCA) | Metabolic syndrome conferences | Type 1 Diabetes Association | Team Novo Nordisk | Nutrition and Metabolism Society | Pediatric diabetes | American Society for Metabolic and Bariatric Surgery |
Societies in Asia-Pacific & Middle East:
Philippine Society of Endocrinology and Metabolism | Philippines Society of Diabetes | Nutrition & Metabolic Diseases, Romania | Diabetes conferences | Colombian Society of Cardiology and Cardiovascular Surgery | Austrian Society for Endocrinology and Metabolism, Austria | Diabetic Foot Society of India, India | Diabetes congress | Diabetic Society of Singapore (Singapore) | Romanian Society of Diabetes Nutrition and Metabolic Diseases | Diabetes Federation of Ireland | Type 2 diabetes conferences | Diabetes South Africa; Society of Endocrine, Metabolism & Diabetes of Southern Africa, South Africa | Hungarian Society of Endocrinology and Metabolism, Hungary | Diabetes treatment conferences | Turkey Society of Endocrinology and Metabolism, Turkey | Costa Rica Association For Endocrinology | Obesity conferences | Diabetes and Nutrition, Costa Rica | National Heart Association of Malaysia, Malaysia | Egyptian Association of Endocrinology | Nutrition conferences | Diabetes and Atherosclerosis, Egypt | Society of Endocrinology and Metabolism, Hungary | Egyptian Society of Endocrinology and Obesity, Egypt | Endocrinology conferences | Diabetes Society of the Chinese Medical Association, China | Fiji National Diabetes Foundation, Fiji | Endocrine Society of India, India | Diabetes conferences 2019 USA | Japan Diabetes Society (Japan) | Korean Diabetes society (Korea) | Saudi Diabetes and Endocrine Association, Saudi Arabia | Diabetes mellitus conferences | Spanish Diabetes Society (Spain) | Netherlands Diabetes Association (Netherland) | Hong Kong Diabetes Federation | Diabetes conferences Europe | Diabetic Association of India | Japan Diabetes Society | Korean Diabetes Association | Norwegian Diabetes Association | Diabetes meeting 2019 | Diabetic Society of Singapore | The International Society for Quality in Health Care (ISQua) | Metabolic syndrome conferences | Indian Diabetic Association | Saudi Diabetes and Endocrine Association (Saudi Arabia) | Nepal Diabetic Society (Nepal) | Diabetes Philippines (Philippines) | Pediatric diabetes | Italian Society of Human Nutrition, Italy | Chinese Diabetes Society | The Diabetes Association of The Republic Of China (Taiwan) | Taiwanese Association of Diabetes | Chinese Medical Association (CMA).
European Societies -
French Diabetics Association | Netherlands Diabetes Association | European Society of Cardiology | Diabetes conferences | Society of Diabetes, Nutrition & Metabolic Diseases | Society of Endocrine, Metabolism & Diabetes of Southern Africa | Type 1 diabetes conferences | Diabetes and Metabolism, Portugal | European Society of Endocrinology and Hormone Research | Austrian Society for Endocrinology and Metabolism | Type 2 diabetes conferences | Hungarian Society of Endocrinology and Metabolism, Hungary | Union of Diabetics of Czech Republic | Italian Society of Human Nutrition | Diabetes treatment conferences | Portuguese Society of Endocrinology | French Diabetes Association (France) | European Society of Endocrinology | Obesity conferences | European Society for Pediatric Endocrinology | European Foundation for the Study of Diabetes (EFSD) | International Diabetes Federation (IDF) | Nutrition conferences | European Foundation for the study of Diabetes | The Immunology of Diabetes Society, Sweden | Diabetological Colombian Federation | Endocrinology conferences | Croatian Diabetes Association | German Diabetes Union (Germany) | Diabetic Association of Portugal | Diabetes conferences 2019 USA | Finnish Diabetes Association | French Diabetics Association (France) | Swedish Diabetes Association (Sweden) | Diabetes congress | Japan Diabetes Society (Japan) | Spanish Society of Endocrinology and Nutrition | Federation of European Nutrition Societies (FENS) | Diabetes conferences Europe | Hungarian Society of Endocrinology and Metabolism | French Diabetics Association | Estonian Diabetes Association | Diabetes meeting 2019 | The Diabetes Association (Italy) | Diabetes Philippines | Polish Diabetes Association | Spanish Diabetes Society | Metabolic syndrome conferences | Swedish Diabetes Association | Swiss Diabetes Society | Diabetes UK | Pediatric diabetes | Diabetes Research and Wellness Foundation | Polish Diabetes Association (Poland) | Swedish Diabetes Association (Sweden) | Diabetes conferences | Spanish Diabetes Society (Spain) | Diabetic Association of Portugal (Portugal) | Netherlands Diabetes Association (Netherlands) | Diabetes Federation of Ireland (Ireland) | Endocrinology conferences | Diabetes Federation of Ireland (Ireland) | Italian Society of Parenteral and Enteral Nutrition, Italy.
American journals -
Diabetes Care | Endocrine Reviews | Diabetes | Thyroid | Diabetes conferences | Journal of Clinical Endocrinology and Metabolism | Journal of Bone and Mineral Research | Type 1 diabetes conferences | American Journal of Physiology - Endocrinology and Metabolism | Obesity | Current Opinion in Lipidology | Diabetes/Metabolism Research and Reviews | Type 2 diabetes conferences | Diabetes Technology and Therapeutics | Molecular Genetics and Metabolism | World Journal of Diabetes | Current Diabetes Reports | Childhood Obesity | Diabetes treatment conferences | Current Opinion in Endocrinology Diabetes and Obesity | Journal of Clinical Densitometry | Obesity Surgery | Obesity conferences | Pancreas | Therapeutic Advances in Endocrinology and Metabolism | Current Osteoporosis Reports | Nutrition conferences | Diabetes and Vascular Disease Research | Journal of diabetes science and technology | Hormones and Cancer | Endocrinology conferences | Endocrine Practice | Andrology | Seminars in Reproductive Medicine | Applied Physiology, Nutrition and Metabolism | Diabetes conferences 2019 USA | Endocrine | Diabetes Therapy | Genes and Nutrition | Journal of Endocrinological Investigation | Diabetes mellitus conferences | Growth Hormone and IGF Research | Dermato-Endocrinology | Diabetes Educator | Islets | Diabetes conferences Europe | Journal of Clinical Hypertension | Metabolic Syndrome and Related Disorders | Diabetes meeting 2019 | Clinical Diabetes | Canadian Journal of Diabetes | Endocrine Pathology | Biological Trace Element Research | Journal of Osteoporosis | Clinical Medicine Insights: Endocrinology and Diabetes |Metabolic syndrome conferences | Diabetes Spectrum | Journal of Thyroid Research | Clinical Reviews in Bone and Mineral Metabolism | Bone Reports | British Journal of Diabetes and Vascular Disease | Pediatric diabetes | Case Reports in Endocrinology | Practical Diabetes | Cardiovascular Endocrinology
Journals in Asia-Pacific & Middle East:-
Journal of Obesity | Journal of Diabetes Research | International Journal of Endocrinology | Diabetes conferences | Current Diabetes Reviews | Endocrine, Metabolic and Immune Disorders - Drug Targets | Journal of Nutrition and Metabolism | Type 1 diabetes conferences | Pediatric Endocrinology Reviews | JCRPE Journal of Clinical Research in Pediatric Endocrinology | Type 2 diabetes conferences | Cholesterol | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | Diabetes treatment conferences | Turk Osteoporoz Dergisi | Iranian Journal of Endocrinology and Metabolism | Obesity conferences | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | Turkish Journal of Endocrinology and Metabolism | Nutrition conferences | International Journal of Diabetes and Metabolism | Open Diabetes Journal | Journal of Diabetes Investigation | Vascular Health and Risk Management | Endocrinology conferences | Journal of Diabetes | Nutrition and Metabolic Insights | Diabetes and Metabolism Journal | Diabetes conferences 2019 USA | Endocrinology and Metabolism | Endocrine Journal | Annals of Pediatric Endocrinology and Metabolism | Diabetes mellitus conferences | Indian Journal of Endocrinology and Metabolism | Clinical Pediatric Endocrinology | Diabetology International | Diabetes conferences Europe | International Journal of Diabetes in Developing Countries | Journal of the ASEAN Federation of Endocrine Societies | Diabetes meeting 2019 | Journal of the Japan Diabetes Society | International Journal of Osteoporosis and Metabolic Disorders | World Journal of Endocrine SurgeryEuropean Journals -
The Lancet Diabetes and Endocrinology | Nature Reviews Endocrinology | Trends in Endocrinology and Metabolism | Diabetes conferences | Obesity Reviews | Diabetologia | Cytokine and Growth Factor Reviews | Type 1 diabetes conferences | Diabetes, Obesity and Metabolism | Pediatric Diabetes | International Journal of Obesity | Psychoneuroendocrinology | Type 2 diabetes conferences | Metabolism: Clinical and Experimental | Cardiovascular Diabetology | Endocrine-Related Cancer | Diabetes treatment conferences | Reviews in Endocrine and Metabolic Disorders | Journal of Endocrinology | European Journal of Endocrinology | Frontiers in Endocrinology | Obesity conferences | Best Practice and Research in Clinical Endocrinology and Metabolism | Journal of Nutritional Biochemistry | Journal of Clinical Lipidology | Nutrition conferences | Nutrition and Diabetes | Diabetic Medicine | Endocrinology conferences | Journal of Neuroendocrinology | Diabetes Research and Clinical Practice | Endocrine Connections | Diabetes conferences 2019 USA | Nutrition and Metabolism | Osteoporosis International | Neuroendocrinology | Nutrition, Metabolism and Cardiovascular Diseases | Diabetes mellitus conferences | Journal of Steroid Biochemistry and Molecular Biology | Clinical Endocrinology | Diabetes and Metabolism | Journal of Diabetes and its Complications | Diabetes conferences Europe | Endocrinology and Metabolism Clinics of North America | Nutrition Research | BMJ Open Diabetes Research and Care | Bone Research | Diabetes congress | Metabolomics | Metabolic Engineering Communications | Calcified Tissue International | Pancreatology | Metabolites | Diabetes meeting 2019 | Hormone Molecular Biology and Clinical Investigation | Journal of Nutritional Science | BMC Endocrine Disorders | Diabetology and Metabolic Syndrome | Metabolic syndrome conferences | Hormone and Metabolic Research | Lipids in Health and Disease | Hormone Research in Pediatrics | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | Primary Care Diabetes | Endocrine development | Journal of Clinical and Translational Endocrinology | Pediatric diabetes | Journal of Diabetes and Metabolic Disorders | Journal of Bone and Mineral Metabolism | Experimental and Clinical Endocrinology and Diabetes | Obesity Research and Clinical Practice | Diabetes conferences | Endocrinology, Diabetes and Metabolism Case Reports | Gynecological Endocrinology | International Journal of Endocrinology and Metabolism | Journal of Musculoskeletal Neuronal Interactions | Type 1 diabetes conferences | International Journal for Vitamin and Nutrition Research | Journal of Pediatric Endocrinology and Metabolism |Type 2 diabetes conferences | Frontiers of Hormone Research | International Journal of Diabetes Mellitus | IJC Metabolic and Endocrine | Clinical Nutrition Experimental | Minerva Gastroenterologica e Dietologica | Diabetes treatment conferences | Thyroid Research | Neuroendocrinology Letters | Journal of Nutrition and Intermediary Metabolism | Journal of the Pancreas | Expert Review of Endocrinology and Metabolism | Endocrinology conferences | Obesity Medicine | Clinical Nutrition ESPEN | Clinical Lipidology | Diabetic Hypoglycemia | European Endocrinology | Open Bone Journal | International Journal of Endocrine Oncology | Diabetes conferences Europe | Mediterranean Journal of Nutrition and Metabolism | Journal of Endocrinology, Metabolism and Diabetes of South Africa | Journal of Diabetes Nursing | Obesity conferences | European Diabetes Nursing | Endocrine Regulations | Acta Endocrinologica | Klinicka Biochemie a Metabolismus | Diabetes congress | Problemy Endokrinologii | Diabetes meeting 2019 | Arterial Hypertension | Current Gynecologic Oncology | Clinical Diabetology | Obesity and Metabolism | Diabetologie Metabolismus Endokrinologie Vyziva | Nutrition conferences | Clinical and Experimental Medical Letters | Diabetologia Kliniczna | Diabetologia Croatica
Diabetes and Endocrinology Companies:
Becton | Dickinson and Company (BDX) | Eli Lilly and Company (LLY) | Johnson & Johnson (JNJ) | Diabetes conferences | Medtronic, Inc. (MDT) | Novo Nordisk (NVO) | Regeneron Pharmaceuticals | Type 1 diabetes conferences | Inc. (REGN) | Sanofi (SNY) | DexCom | Inc. (DXCM) |Type 2 diabetes conferences | Insulet Corporation (PODD) | Myriad Genetics | Inc. (MYGN) | Diabetes treatment conferences | Lexicon Pharmaceuticals| MannKind Corporation (MNKD) | Obesity conferences | Tandem Diabetes Care | Inc. (TNDM) | Victoza, Levemir | Humalog | NovoLog | Invokana | Humulin | Trulicity | Onglyza | Teva Pharmaceutical Industries | Nutrition conferences | Takeda Pharmaceutical | Sanofi | Novon Nordisk | Regeneron Pharmaceuticals | Bristol-Myers Squibb | Endocrinology conferences | Novartis | Lexicon Pharmaceuticals | ManKind Corporation | Tandem Diabetes Care | Diabetes conferences 2019 USA | Abbott Laboratories | Eli Lilly & Co, Levemir | Roche | GlaxoSmithKline | Diabetes congress | Fidia Farmaceutici | ACS DOBFAR | Angelini | Pfizer | Diabetes conferences Europe | Recordati | Apharm | Dipharma | CellPly | Newron Pharmaceuticals | Diabetes meeting 2019 | Zambon | Charles River Laboratories| AbbVie | Adienne Pharma and Biotech | Metabolic syndrome conferences | CordenPharma | VitalMED | Diatheva | Silicon Biosystems | Flamma | Pediatric diabetes | Menarini | Patheon | SI-BONE | Bayer | Baxter | Procus | Inc. (LXRX) |
Diabetes and Endocrinology Jobs :
Jobs in America –
Medical Director | UCLA Department of Endocrinology | Associate Medical Director of Endocrinology | Diabetes conferences | Chair of Endocrinology | Physician- Endocrinology | Neuroendocrinology | Obesity conferences | Endocrinologist | Nutritionist | Endocrinology Doctor | Endocrinology conferences | Pediatric diabetes | Endocrinology Professor | Chief Medical Officer | UCLA | Type 1 diabetes conferences | Associate Medical Director | Chair of Diabetes and Endocrinology department | Doctor | Type 2 diabetes conferences | Diabetes Professor
Assistant/Associate Professor (Fellowship Director) | Diabetes Transition Coordinator (Diabetes Center) | Chief Operational Officer | Diabetes conferences | Chief of Pediatric Endocrinology | Endocrinologist Physician | Research Specialist II | Type 1 diabetes conferences | Endocrinologist | Childhood Obesity Doctor | Neuropathologist | Evidence Analyst | Type 2 diabetes conferences | Program Assistant | Managing Director | Consultant in Endocrinology | Specialist Physician/s | Diabetes treatment conferences | Healthcare Position/s | Endocrinology Consultant/Attending Physician | IVF Reproductive Endocrinologist Consultant | Obesity conferences | Medical Consultants | DHA Endocrinologist | Endocrinologist Doctors | Nutrition conferences | Consultant Gastroenterologist in Hospital | Consultants in Diabetes and Endocrinology | Medical Officer | Endocrinology conferences | Professor Endocrinology | Assistant/Associate Professor | Diabetes Transition Coordinator | Diabetes congress | Chief Operational Officer | Chief of Pediatric Endocrinology | Diabetologist and Endocrinologist Physician | Diabetes mellitus conferences | Endocrinology Laboratory | Diabetes meetings 2019 | Neuropathologist | Diabetes conferences Europe | Specialist Physician/s | Healthcare Position/s | Managing Director
Jobs in Europe –
Academic Endocrinologist | Internist | Diabetes conferences | Family Practitioner or Endocrinologist | Pediatric Endocrinologist | Assistant/Associate Professor | Type 1 diabetes conferences | Endocrinologist | Physician – Endocrinology | Endocrinology Practice | Type 2 diabetes conferences | Physician – Endocrinology | Diabetes and Metabolism | Internal medicine - endocrinology faculty position | Physician - Endocrinology | Diabetes congress | Diabetes & Metabolism | Physician assistant | Family Practitioner | Obesity conferences | Pediatric Diabetologist | Assistant/Associate Professor | Endocrinologist | Nutrition conferences| Endocrinology physician | Diabetes and Metabolism Physician | Pediatric conferences | Endocrinology conferences | Faculty Position | Endocrinology | Physician-Endocrinology | Physician Assistant